drugset / Press release
American Association for Cancer Research (AACR) 2019 – STRO-001 Poster
2019-04-11 · Sutro Biopharma, Inc. · original sutrobio.com ↗
A Phase 1 Open-Label, Safety, Pharmacokinetic, And Preliminary Efficacy Study Of STRO-001, An Anti-CD74 Antibody Drug Conjugate, In Patients With Advanced B-Cell Malignancies, NCT03424603
The release as fetched from its publisher. sutrobio.com ↗